- Report
- October 2024
- 198 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- September 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- August 2024
- 80 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 380 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,176GBP
- Report
- October 2024
- 70 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- November 2024
- 250 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- December 2022
- 153 Pages
Global
From €2389EUR$2,625USD£2,048GBP
€4778EUR$5,250USD£4,096GBP
- Report
- August 2022
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2022
- 119 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- November 2023
- 30 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- November 2023
- 30 Pages
Global
From €2958EUR$3,250USD£2,536GBP

Cisplatin is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It works by damaging the DNA of cancer cells, preventing them from growing and dividing. Cisplatin is often used in combination with other drugs to increase its effectiveness. It is administered intravenously and can cause side effects such as nausea, vomiting, and hair loss.
The market for cisplatin in the treatment of lung cancer is highly competitive, with many companies offering their own versions of the drug. Companies such as Bristol-Myers Squibb, Pfizer, and Merck & Co. are all major players in the market. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of the drug.
In the market for cisplatin, companies such as Bristol-Myers Squibb, Pfizer, Merck & Co., Teva Pharmaceuticals, and Mylan are all major players. Show Less Read more